A First-in-human, Proof of Concept Study of CPK850 in Patients With RLBP1 Retinitis Pigmentosa
Clinical trial NCT03374657 · COMPLETED
Trial details
- NCT number
- NCT03374657
- Sponsor
- Novartis Pharmaceuticals
- Status
- COMPLETED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2018-08-22
- Primary completion
- 2026-05-12
- Enrollment
- 12
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.